
Mildronate dihydrate NEW
Price | Get Latest Price | |
Package | 1kg | 25kg |
Min. Order: | 1kg |
Supply Ability: | 800kg |
Update Time: | 2025-03-06 |
Product Details
Product Name: Mildronate dihydrate | CAS No.: 86426-17-7 |
Min. Order: 1kg | Purity: 0.99 |
Supply Ability: 800kg | Release date: 2025/03/06 |
?Mildronate Dihydrate | EP-Certified Cardiovascular API | Bulk Supplier for Cardioprotective Therapies?
?Google Keywords?: Mildronate dihydrate bulk supplier, meldonium dihydrate API, cardiovascular drug, EP-certified cardioprotective agent
?? ?Product Overview?
Mildronate Dihydrate (CAS 86426-17-7) is a cardioprotective agent and structural analog of L-carnitine, primarily used to treat myocardial ischemia, angina, and improve exercise tolerance. It inhibits γ-butyrobetaine hydroxylase (BBOX1) and carnitine biosynthesis, reducing fatty acid oxidation and enhancing cellular energy metabolism under hypoxic conditions. Approved for clinical use, it is essential in cardiovascular therapeutics and metabolic research?13.
?? ?Key Advantages?
?High Purity?: ≥98% HPLC purity compliant with ?EP standards? for pharmaceutical use?15.
?Solubility?: White crystalline powder, highly soluble in water (>40 mg/mL) for oral or injectable formulations?56.
?Bulk Customization?: Available in 1kg–25kg batches with COA, MSDS, and stability documentation?12.
?? ?Applications?
?Cardiovascular Therapy?: Reduces angina symptoms and improves cardiac function in ischemic heart disease?13.
?Metabolic Regulation?: Inhibits carnitine-dependent fatty acid transport for energy metabolism modulation?47.
?Sports Medicine?: Enhances exercise capacity in patients with cardiovascular limitations (under medical supervision)?34.
?? ?Quality Compliance?
Certified under ?EP guidelines? with residual solvents <10 ppm and heavy metals <20 ppm?15.
Stability tested for 24 months when stored at 2-8°C in airtight, moisture-resistant packaging?15.
?? ?Market Trends?
The global cardiovascular drug market is projected to grow at ?5.3% CAGR (2025-2030)?, driven by rising demand for ischemia management solutions. Mildronate’s dual action on energy metabolism and cardioprotection positions it as a key therapeutic agent?34.
Company Profile Introduction
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/1kg |
VIP1Y
|
Hebei Junhua Import and Export Co., LTD
|
2025-02-26 | |
$90.00/1KG |
VIP1Y
|
Shandong Xuhuang New material CoLTD
|
2025-02-21 | |
$0.00/1g |
VIP1Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-10-16 | |
$0.00/1KG |
VIP2Y
|
Hangzhou Hyper Chemicals Limited
|
2024-09-14 | |
$1.00/1g |
VIP1Y
|
Apeloa production Co.,Limited
|
2024-07-19 | |
$13.00/1kg |
VIP1Y
|
Hebei Ganmiao New material Technology Co., LTD
|
2024-06-19 | |
$35.00/1kg |
Hebei Xinsheng New Material Technology Co., LTD.
|
2023-10-13 | ||
$0.00/1g |
VIP3Y
|
shandong perfect biotechnology co.ltd
|
2023-08-03 | |
$0.00/25kg |
PNP Biotech Co. Ltd
|
2022-10-19 | ||
$0.00/1g |
Hebei Bonster Technology Co.,Limited
|
2022-10-18 |
- Since: 2018-06-08
- Address: Biolake.858 high-tech avenue,Wuhan
+86-+undefined-+86 13343427080
sales@biocarchem.com